✦ LIBER ✦

606 Effect of peginterferon alpha-2b and ribavirin on histological lesions in patients with hepatitis C virus (HCV) and HCV/HIV co-infection: An open-label trial

✍ Scribed by R. Sarmento e Castro; A. Horta; H. Coelho; O. Vasconcelos; J. Méndez; J. Seabra; A.P. Tavares; O. Fortes; M. Duarte; N. Pires; L. Chaves; J.P. Pires; L. Pinho; E. Carneiro

Book ID: 117374882
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 110 KB
Volume: 44
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(06)80606-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of peginterferon alpha-2b and rib

Impact of peginterferon alpha-2b and ribavirin treatment on liver tissue in patients with HCV or HCV–HIV co-infection

✍ Rui Sarmento-Castro; Ana Horta; Olga Vasconcelos; Helena Coelho; Josefina Mendez 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 205 KB

Cost-effectiveness of peginterferon alfa

Cost-effectiveness of peginterferon alfa-2a (40 kDa) plus ribavirin in patients with HIV and hepatitis C virus co-infection

✍ John Hornberger; Francesca J. Torriani; Douglas T. Dieterich; Norbert Bräu; Mark 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 227 KB

PGI2 IS THERE ANY DIFFERENCE BETWEEN THE

PGI2 IS THERE ANY DIFFERENCE BETWEEN THE EFFECTS OF THERAPY WITH PEGINTERFERON-ALPHA-2A VERSUS STANDARD-DOSE PEGINTERFERON-ALPHA-2B? A META-ANALYSIS COMPARING BOTH TREATMENTS PLUS RIBAVIRIN IN GENOTYPE 1/4 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION PATIENTS

✍ FMR Barros; H Cheinquer; LG Borges; E Santos 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Emergence of occult minority genotype 2b

Emergence of occult minority genotype 2b hepatitis C infection in an HIV-1-co-infected patient treated for genotype 5a HCV infection with 48 weeks of pegylated-interferon-α 2b and ribavirin

✍ A.J. Buckton; R. Kulasegaram; S.L. Ngui; M. Fisher; R. James; S. Rangarajan; C.G 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 362 KB

P1234 SAFETY AND EFFICACY OF MK-5172 PLU

P1234 SAFETY AND EFFICACY OF MK-5172 PLUS PEGINTERFERON ALFA-2b AND RIBAVIRIN (PR) IN CIRRHOTIC AND NON-CIRRHOTIC TREATMENT-NAIVE PATIENTS WITH HEPATITIS C VIRUS (HCV) GENOTYPE (G)1 INFECTION

✍ Hezode, C.; Bruno, S.; Jacobson, I.; Serfaty, L.; Kwo, P.; Zhou, A.; Gilbert, C. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Safety and efficacy of an induction dose

Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: the CORAL-1 multicentre pilot study

✍ C. Tural; R. Solà; R. Rubio; M. Santín; R. Planas; C. Quereda; J. Berenguer; M. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 518 KB